Evaluation of Tiotropium 2.5 and 5 µg Once Daily Delivered Via the Respimat Inhaler Compared to Placebo in Patient With Moderate to Severe Persistent Asthma

PHASE3CompletedINTERVENTIONAL
Enrollment

285

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions
Asthma
Interventions
DRUG

Tiotropium Respimat

Tiotropium high dose once daily delivered with Respimat inhaler

DRUG

Placebo Respimat

Tiotropium placebo once daily delivered with Respimat inhaler

DRUG

Tiotropium Respimat

Tiotropium low dose once daily delivered with Respimat inhaler

Trial Locations (55)

Unknown

205.464.81020 Boehringer Ingelheim Investigational Site, Asahikawa, Hokkaido

205.464.81031 Boehringer Ingelheim Investigational Site, Atsugi, Kanagawa

205.464.81029 Boehringer Ingelheim Investigational Site, Chigasaki, Kanagawa

205.464.81011 Boehringer Ingelheim Investigational Site, Chino, Nagano

205.464.81050 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

205.464.81051 Boehringer Ingelheim Investigational Site, Chuo-ku, Tokyo

205.464.81006 Boehringer Ingelheim Investigational Site, Edogawa-ku, Tokyo

205.464.81010 Boehringer Ingelheim Investigational Site, Fujisawa, Kanagawa

205.464.81016 Boehringer Ingelheim Investigational Site, Fukuoka, Fukuoka

205.464.81004 Boehringer Ingelheim Investigational Site, Hanno, Saitama

205.464.81040 Boehringer Ingelheim Investigational Site, Himeji, Hyogo

205.464.81041 Boehringer Ingelheim Investigational Site, Himeji, Hyogo

205.464.81053 Boehringer Ingelheim Investigational Site, Himeji, Hyogo

205.464.81007 Boehringer Ingelheim Investigational Site, Hino, Tokyo

205.464.81015 Boehringer Ingelheim Investigational Site, Hiroshima, Hiroshima

205.464.81002 Boehringer Ingelheim Investigational Site, Hitachinaka, Ibaraki

205.464.81048 Boehringer Ingelheim Investigational Site, Iizuka, Fukuoka

205.464.81005 Boehringer Ingelheim Investigational Site, Itabashi-ku, Tokyo

205.464.81033 Boehringer Ingelheim Investigational Site, Kaga, Ishikawa

205.464.81017 Boehringer Ingelheim Investigational Site, Kagoshima, Kagoshima

205.464.81023 Boehringer Ingelheim Investigational Site, Kamogawa, Chiba

205.464.81024 Boehringer Ingelheim Investigational Site, Kisarazu, Chiba

205.464.81047 Boehringer Ingelheim Investigational Site, Kitakyusyu,Fukuoka

205.464.81008 Boehringer Ingelheim Investigational Site, Kiyose, Tokyo

205.464.81046 Boehringer Ingelheim Investigational Site, Kochi, Kochi

205.464.81025 Boehringer Ingelheim Investigational Site, Kodaira, Tokyo

205.464.81022 Boehringer Ingelheim Investigational Site, Koshigaya, Saitama

205.464.81043 Boehringer Ingelheim Investigational Site, Kurashiki, Okayama

205.464.81044 Boehringer Ingelheim Investigational Site, Kure, Hiroshima

205.464.81014 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto

205.464.81038 Boehringer Ingelheim Investigational Site, Kyoto, Kyoto

205.464.81003 Boehringer Ingelheim Investigational Site, Maebashi, Gumma

205.464.81042 Boehringer Ingelheim Investigational Site, Matsue, Shimane

205.464.81026 Boehringer Ingelheim Investigational Site, Minato-ku, Tokyo

205.464.81012 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

205.464.81013 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

205.464.81034 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

205.464.81035 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

205.464.81036 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

205.464.81037 Boehringer Ingelheim Investigational Site, Nagoya, Aichi

205.464.81001 Boehringer Ingelheim Investigational Site, Obihiro, Hokkaido

205.464.81018 Boehringer Ingelheim Investigational Site, Obihiro, Hokkaido

205.464.81054 Boehringer Ingelheim Investigational Site, Oita, Oita

205.464.81055 Boehringer Ingelheim Investigational Site, Oita, Oita

205.464.81039 Boehringer Ingelheim Investigational Site, Osaka, Osaka

205.464.81049 Boehringer Ingelheim Investigational Site, Saga, Saga

205.464.81019 Boehringer Ingelheim Investigational Site, Sapporo, Hokkaido

205.464.81021 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

205.464.81027 Boehringer Ingelheim Investigational Site, Setagaya-Ku, Tokyo

205.464.81028 Boehringer Ingelheim Investigational Site, Setagaya-ku, Tokyo

205.464.81045 Boehringer Ingelheim Investigational Site, Toon, Ehime

205.464.81009 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

205.464.81052 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

205.464.81030 Boehringer Ingelheim Investigational Site, Yokosuka, Kanagawa

205.464.81032 Boehringer Ingelheim Investigational Site, Zama

Sponsors

Collaborators (1)

All Listed Sponsors
collaborator

Pfizer

INDUSTRY

lead

Boehringer Ingelheim

INDUSTRY